Skip to main content Help with accessibility Skip to main navigation

RELUGOLIX tablets (Orgovyx®▼) for hormone-sensitive prostate cancer

CCG Approval Status:

Date Added: 23 - Mar - 2023
Body System:
Grey

The Cheshire and Merseyside Interim Area Prescribing Group does not currently recommend the prescribing of RELUGOLIX tablets (Orgovyx®▼) for hormone-sensitive prostate cancer.